Topics

Pharmaceutical Industry
Experimental Ebola drug 'exhausted,' as experts debate ethical use
Experimental Ebola drug 'exhausted,' as experts debate ethical use

As U.S. medical experts raised concerns Tuesday about the use of experimental drugs to treat the Ebola virus, makers of the unapproved medication ZMapp said their supply has been "exhausted." In a statement published online late Monday, Mapp Biopharmaceuticals Inc., of San Diego, said it had complied with all legal requests for the drug and provided the medication "at no cost." The statement did not say how many doses were distributed or who had received them. Company officials have said they are legally prohibited from disclosing patient information. "The available supply of ZMapp has been exhausted," the statement read. To date, a handful of private...

Loading